Mutational correlates of response to hypomethylating agent therapy in acute myeloid leukemia

Haematologica. 2016 Nov;101(11):e457-e460. doi: 10.3324/haematol.2016.148999. Epub 2016 Jul 14.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use
  • DNA (Cytosine-5-)-Methyltransferases / genetics
  • DNA Methylation / genetics
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics
  • Mutation Rate
  • Mutation*

Substances

  • Antimetabolites, Antineoplastic
  • DNA (Cytosine-5-)-Methyltransferases
  • DNA methyltransferase 3A